186 related articles for article (PubMed ID: 1702330)
1. Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59.
Hamilton KK; Ji Z; Rollins S; Stewart BH; Sims PJ
Blood; 1990 Dec; 76(12):2572-7. PubMed ID: 1702330
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
3. H19, a surface membrane molecule involved in T-cell activation, inhibits channel formation by human complement.
Whitlow MB; Iida K; Stefanova I; Bernard A; Nussenzweig V
Cell Immunol; 1990 Mar; 126(1):176-84. PubMed ID: 1689219
[TBL] [Abstract][Full Text] [Related]
4. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
5. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface.
Hattori R; Hamilton KK; McEver RP; Sims PJ
J Biol Chem; 1989 May; 264(15):9053-60. PubMed ID: 2470750
[TBL] [Abstract][Full Text] [Related]
6. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
Meri S; Morgan BP; Davies A; Daniels RH; Olavesen MG; Waldmann H; Lachmann PJ
Immunology; 1990 Sep; 71(1):1-9. PubMed ID: 1698710
[TBL] [Abstract][Full Text] [Related]
7. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.
Farkas I; Baranyi L; Ishikawa Y; Okada N; Bohata C; Budai D; Fukuda A; Imai M; Okada H
J Physiol; 2002 Mar; 539(Pt 2):537-45. PubMed ID: 11882685
[TBL] [Abstract][Full Text] [Related]
8. Regulatory control of complement on blood platelets. Modulation of platelet procoagulant responses by a membrane inhibitor of the C5b-9 complex.
Sims PJ; Rollins SA; Wiedmer T
J Biol Chem; 1989 Nov; 264(32):19228-35. PubMed ID: 2808422
[TBL] [Abstract][Full Text] [Related]
9. Amplified gene expression in CD59-transfected Chinese hamster ovary cells confers protection against the membrane attack complex of human complement.
Zhao J; Rollins SA; Maher SE; Bothwell AL; Sims PJ
J Biol Chem; 1991 Jul; 266(20):13418-22. PubMed ID: 1712784
[TBL] [Abstract][Full Text] [Related]
10. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59.
Kennedy SP; Rollins SA; Burton WV; Sims PJ; Bothwell AL; Squinto SP; Zavoico GB
Transplantation; 1994 May; 57(10):1494-501. PubMed ID: 7515200
[TBL] [Abstract][Full Text] [Related]
11. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
Ninomiya H; Sims PJ
J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
[TBL] [Abstract][Full Text] [Related]
12. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T
Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913
[TBL] [Abstract][Full Text] [Related]
13. Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria.
Wiedmer T; Hall SE; Ortel TL; Kane WH; Rosse WF; Sims PJ
Blood; 1993 Aug; 82(4):1192-6. PubMed ID: 7688991
[TBL] [Abstract][Full Text] [Related]
14. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
Lehto T; Meri S
J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
[TBL] [Abstract][Full Text] [Related]
15. Identity of a peptide domain of human C9 that is bound by the cell-surface complement inhibitor, CD59.
Chang CP; Hüsler T; Zhao J; Wiedmer T; Sims PJ
J Biol Chem; 1994 Oct; 269(42):26424-30. PubMed ID: 7523406
[TBL] [Abstract][Full Text] [Related]
16. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
17. Calcium-loaded erythrocytes have a defect in complement regulation distinct from that resulting from exposure to 2-aminoethylisothiouronium bromide.
Test ST; Mitsuyoshi J
Blood; 1995 Oct; 86(7):2799-806. PubMed ID: 7545473
[TBL] [Abstract][Full Text] [Related]
18. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
Tomlinson S; Whitlow MB; Nussenzweig V
J Immunol; 1994 Feb; 152(4):1927-34. PubMed ID: 7509832
[TBL] [Abstract][Full Text] [Related]
19. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex.
Hamilton KK; Hattori R; Esmon CT; Sims PJ
J Biol Chem; 1990 Mar; 265(7):3809-14. PubMed ID: 2105954
[TBL] [Abstract][Full Text] [Related]
20. Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice.
Fu X; Ju J; Lin Z; Xiao W; Li X; Zhuang B; Zhang T; Ma X; Li X; Ma C; Su W; Wang Y; Qin X; Liang S
Sci Rep; 2016 Jul; 6():30239. PubMed ID: 27444648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]